- Home
- BIAF vs IMCC Comparison
BIAF vs IMCC Comparison
Compare BIAF & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- IMCC
- Stock Information
- Founded
- BIAF 2014
- IMCC 1980
- Country
- BIAF United States
- IMCC Israel
- Employees
- BIAF N/A
- IMCC N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- BIAF Health Care
- IMCC Health Care
- Exchange
- BIAF Nasdaq
- IMCC Nasdaq
- Market Cap
- BIAF 12.2M
- IMCC 11.8M
- IPO Year
- BIAF 2022
- IMCC N/A
- Fundamental
- Price
- BIAF $0.23
- IMCC $2.66
- Analyst Decision
- BIAF Hold
- IMCC
- Analyst Count
- BIAF 1
- IMCC 0
- Target Price
- BIAF N/A
- IMCC N/A
- AVG Volume (30 Days)
- BIAF 706.3K
- IMCC 50.5K
- Earning Date
- BIAF 08-14-2025
- IMCC 08-12-2025
- Dividend Yield
- BIAF N/A
- IMCC N/A
- EPS Growth
- BIAF N/A
- IMCC N/A
- EPS
- BIAF N/A
- IMCC N/A
- Revenue
- BIAF $7,681,059.00
- IMCC $38,430,631.00
- Revenue This Year
- BIAF N/A
- IMCC $47.12
- Revenue Next Year
- BIAF $20.00
- IMCC $12.83
- P/E Ratio
- BIAF N/A
- IMCC N/A
- Revenue Growth
- BIAF 4.99
- IMCC 5.08
- 52 Week Low
- BIAF $0.16
- IMCC $1.29
- 52 Week High
- BIAF $2.26
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- BIAF 32.85
- IMCC 47.41
- Support Level
- BIAF $0.27
- IMCC $2.48
- Resistance Level
- BIAF $0.30
- IMCC $3.13
- Average True Range (ATR)
- BIAF 0.02
- IMCC 0.32
- MACD
- BIAF -0.01
- IMCC -0.00
- Stochastic Oscillator
- BIAF 2.58
- IMCC 38.16
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.